News

XWELL Reports Fiscal Year 2024 Results

  • NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), a pioneer in democratizing wellness, today reported results for the year ended December 31, 2024.
    04/15/2025

XWELL Announces Plan for Strategic Investment in Medical Spas to Advance Wellness and Beauty Offerings

  • NEW YORK, March 13, 2025 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), a pioneer in democratizing wellness, today announced plans to acquire select medical spas by the end of 2025, leveraging its recent $4 million private placement to expand into the high-growth wellness and beauty sector. This strategic move aligns with XWELL's mission to “liberate wellness” by creating a seamless continuum of care, extending beyond airports and into metropolitan areas where demand for advanced beauty and wellness treatments is rising.
    03/13/2025
Profitability
Dividends
Income Statement
Balance Sheet
Cash Flow Statement
Symbol Frequently Asked Questions

XWELL, Inc. (XWEL) can sell. Click on Rating Page for detail.

The price of XWELL, Inc. (XWEL) is 0.8617 and it was updated on 2025-05-09 01:34:56.

Currently XWELL, Inc. (XWEL) is in undervalued.

News
    
News

XWELL Announces Closing of $4 Million Private Placement Consisting of Convertible Preferred Stock and Warrants

  • NEW YORK, Jan. 15, 2025 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, today announced the closing of its private placement offering of $4 million of the Company's newly designated Series G Convertible Preferred Stock. The Company also issued to the investors in the private placement Series A warrants and Series B warrants exercisable for the Company's common stock.
    Wed, Jan. 15, 2025

XWELL Announces Senior Leadership Appointments and Changes

  • Ian Brown Appointed XWELL's CFO Succeeding Suzanne Scrabis Peter Vermeulen Joins XWELL as its New Head of Human Resources Mike Heronime Joins XWELL as its New Marketing Director NEW YORK, Jan. 07, 2025 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, today announced new senior leadership appointments to support the Company's strategic growth and business objectives. Ian Brown joined the Company as its new Chief Financial Officer on January 6, 2025, succeeding Suzanne Scrabis, whose separation is effective as of January 8, 2025.
    Tue, Jan. 07, 2025

Open Letter to XWELL Shareholders from CEO Ezra Ernst

  • NEW YORK, Dec. 05, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, today announced that the Company's Chief Executive Officer, Ezra Ernst has issued an open letter to shareholders. The letter provides a summary of the Company's business objectives for 2025 which are aimed to liberate wellness, unify its brands, and accelerate growth.
    Thu, Dec. 05, 2024

XWELL, Inc. (XWEL) Q3 2024 Earnings Call Transcript

  • XWELL, Inc. (NASDAQ:XWEL ) Q3 2024 Earnings Conference Call November 14, 2024 5:00 PM ET Company Participants Suzanne Scrabis – Chief Financial Officer Ezra Ernst – Chief Executive Officer Conference Call Participants Operator Good day, and welcome to the XWELL, Inc. Third Quarter 2024 Results Conference Call. All participants will be in a listen-only mode.
    Thu, Nov. 14, 2024

XWELL, Inc. Reports Third Quarter 2024 Results

  • NEW YORK, Nov. 14, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, today reported results for the third quarter and nine-month period ended September 30, 2024.
    Thu, Nov. 14, 2024
SEC Filings
SEC Filings

XWELL, Inc. (XWEL) - S-3/A

  • SEC Filings
  • 04/29/2025

XWELL, Inc. (XWEL) - DEFA14A

  • SEC Filings
  • 02/28/2025

XWELL, Inc. (XWEL) - DEF 14A

  • SEC Filings
  • 02/28/2025

XWELL, Inc. (XWEL) - PRE 14A

  • SEC Filings
  • 02/18/2025

XWELL, Inc. (XWEL) - S-3

  • SEC Filings
  • 02/07/2025

XWELL, Inc. (XWEL) - D

  • SEC Filings
  • 01/28/2025

XWELL, Inc. (XWEL) - 4

  • SEC Filings
  • 01/24/2025

XWELL, Inc. (XWEL) - 3

  • SEC Filings
  • 01/24/2025

XWELL, Inc. (XWEL) - 4

  • SEC Filings
  • 11/18/2024

XWELL, Inc. (XWEL) - 4

  • SEC Filings
  • 09/13/2024

XWELL, Inc. (XWEL) - DEFA14A

  • SEC Filings
  • 09/05/2024

XWELL, Inc. (XWEL) - 4

  • SEC Filings
  • 09/05/2024

XWELL, Inc. (XWEL) - DEF 14A

  • SEC Filings
  • 08/21/2024

XWELL, Inc. (XWEL) - PRER14A

  • SEC Filings
  • 08/16/2024

XWELL, Inc. (XWEL) - DEFA14A

  • SEC Filings
  • 08/16/2024

XWELL, Inc. (XWEL) - 8-A12B

  • SEC Filings
  • 08/16/2024

XWELL, Inc. (XWEL) - SC 13D/A

  • SEC Filings
  • 08/13/2024

XWELL, Inc. (XWEL) - DEFA14A

  • SEC Filings
  • 08/13/2024

XWELL, Inc. (XWEL) - SC 13G

  • SEC Filings
  • 08/09/2024

XWELL, Inc. (XWEL) - 424B5

  • SEC Filings
  • 08/07/2024

XWELL, Inc. (XWEL) - PREC14A

  • SEC Filings
  • 08/02/2024

XWELL, Inc. (XWEL) - SC 13D/A

  • SEC Filings
  • 07/22/2024

XWELL, Inc. (XWEL) - DEFA14A

  • SEC Filings
  • 07/22/2024

XWELL, Inc. (XWEL) - 4

  • SEC Filings
  • 07/22/2024

XWELL, Inc. (XWEL) - DEFA14A

  • SEC Filings
  • 07/19/2024

XWELL, Inc. (XWEL) - SC 13D

  • SEC Filings
  • 06/17/2024

XWELL, Inc. (XWEL) - SC 13G/A

  • SEC Filings
  • 02/13/2024

XWELL, Inc. (XWEL) - 4

  • SEC Filings
  • 02/07/2024

XWELL, Inc. (XWEL) - 4

  • SEC Filings
  • 01/10/2024

XWELL, Inc. (XWEL) - 3

  • SEC Filings
  • 01/10/2024

XWELL, Inc. (XWEL) - 4

  • SEC Filings
  • 11/01/2023

XWELL, Inc. (XWEL) - EFFECT

  • SEC Filings
  • 10/02/2023

XWELL, Inc. (XWEL) - S-3

  • SEC Filings
  • 08/04/2023

XWELL, Inc. (XWEL) - DEF 14A

  • SEC Filings
  • 07/24/2023

XWELL, Inc. (XWEL) - 4/A

  • SEC Filings
  • 07/21/2023

XWELL, Inc. (XWEL) - 4

  • SEC Filings
  • 07/21/2023

XWELL, Inc. (XWEL) - PRE 14A

  • SEC Filings
  • 07/14/2023

XWELL, Inc. (XWEL) - 4

  • SEC Filings
  • 07/12/2023

XWELL, Inc. (XWEL) - 3

  • SEC Filings
  • 07/12/2023

XWELL, Inc. (XWEL) - 4

  • SEC Filings
  • 06/16/2023

XWELL, Inc. (XWEL) - 4

  • SEC Filings
  • 05/31/2023

XWELL, Inc. (XWEL) - 4

  • SEC Filings
  • 05/30/2023

XWELL, Inc. (XWEL) - 4/A

  • SEC Filings
  • 01/09/2023

XWELL, Inc. (XWEL) - 4

  • SEC Filings
  • 01/09/2023

XWELL, Inc. (XWEL) - S-8

  • SEC Filings
  • 10/25/2022

XWELL, Inc. (XWEL) - DEF 14A

  • SEC Filings
  • 08/29/2022

XWELL, Inc. (XWEL) - PRE 14A

  • SEC Filings
  • 08/16/2022

XWELL, Inc. (XWEL) - 424B3

  • SEC Filings
  • 05/24/2022

XWELL, Inc. (XWEL) - S-3/A

  • SEC Filings
  • 05/17/2022

XWELL, Inc. (XWEL) - CORRESP

  • SEC Filings
  • 05/17/2022

XWELL, Inc. (XWEL) - CORRESP

  • SEC Filings
  • 05/12/2022

XWELL, Inc. (XWEL) - AW

  • SEC Filings
  • 05/12/2022

XWELL, Inc. (XWEL) - S-3/A

  • SEC Filings
  • 05/11/2022

XWELL, Inc. (XWEL) - CORRESP

  • SEC Filings
  • 05/11/2022

XWELL, Inc. (XWEL) - UPLOAD

  • SEC Filings
  • 04/07/2022

XWELL, Inc. (XWEL) - S-8

  • SEC Filings
  • 03/31/2022

XWELL, Inc. (XWEL) - S-3

  • SEC Filings
  • 03/31/2022

XWELL, Inc. (XWEL) - SC 13G/A

  • SEC Filings
  • 02/11/2022

XWELL, Inc. (XWEL) - DEFA14A

  • SEC Filings
  • 08/20/2021

XWELL, Inc. (XWEL) - DEF 14A

  • SEC Filings
  • 08/20/2021
Press Releases
StockPrice Release
More Headlines
News

XWELL, Inc. to Report Third Quarter 2024 Results on Thursday, November 14, 2024

  • NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, today announced that it will report third quarter 2024 financial results, on Thursday, November 14, 2024, after the market close. The announcement will be followed by a webcast and conference call at 5:00 p.m.
  • 11/12/2024

ThredUp And 2 Other Stocks Under $2 Executives Are Buying

  • The Dow Jones index closed higher by around 300 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects.
  • 09/16/2024

XWELL Appoints Ezra Ernst as New President and Chief Executive Officer

  • Strategic leadership change will drive further growth and expansion among core business units Strategic leadership change will drive further growth and expansion among core business units
  • 09/05/2024

XWELL Announces Partnership with Priority Pass

  • Partnership will bring growth opportunities and expands XpresSpa's brand to more travelers Partnership will bring growth opportunities and expands XpresSpa's brand to more travelers
  • 08/26/2024

XWELL, Inc. Adopts Tax Benefits Preservation Plan

  • NEW YORK, Aug. 16, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) (the “Company”) announced today that its Board of Directors has adopted a Tax Benefits Preservation Plan (the “Plan”) intended to preserve the value of certain of the Company's tax attributes related to previously recorded net operating losses (the “Tax Attributes”).
  • 08/16/2024

XWELL, Inc. Reports Second Quarter 2024 Results

  • NEW YORK, Aug. 14, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, today reported results for the second quarter ended June 30, 2024.
  • 08/14/2024

XWELL Comments on CPC's Withdrawal of Threatened Proxy Fight and Related Lawsuit

  • NEW YORK, Aug. 13, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) (“XWELL” or the “Company”), an authority in wellness solutions for people on the go, today issued the following statement in response to CPC Pain & Wellness SPV, LLC's (“CPC”) decision to withdraw its threatened proxy fight and related lawsuit against XWELL, in connection with the Company's 2024 annual meeting of stockholders (the “2024 Annual Meeting”).
  • 08/13/2024

XWELL Announces Closing of $1.4 Million Registered Direct Offering Priced At Premium to Market

  • NEW YORK, Aug. 08, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) (“XWELL” or the “Company”), an authority in wellness solutions for people on the go, today announced the closing of its previously announced registered direct offering priced at a premium to market for the issuance and sale of an aggregate of 652,705 shares of its common stock, par value $0.01 per share, at a purchase price of $2.18 per share.
  • 08/08/2024

CPC Issues Letter to Fellow XWELL, Inc. Shareholders Revealing Intention Behind Recent Schedule 13D Filing & Lawsuit Against Entrenched Board of Directors

  • NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) --  Today, CPC Pain & Wellness SPV, LLC (“CPC”), a significant XWELL, Inc. (Nasdaq: XWEL) (“XWELL” or the “Company”) shareholder that beneficially owns 394,200 or 9.42% of XWELL's outstanding shares, issued the below letter to its fellow shareholders. The letter informs shareholders of CPC's recent lawsuit filing against the incumbent members of XWELL's Board of Directors for breach of their fiduciary duties and for the Board's wrongful and inequitable efforts to prevent CPC from nominating a competing slate of directors and consequently denying shareholders the opportunity to choose who they elect to XWELL's Board at the upcoming annual shareholder meeting. In its letter, CPC details how current Board members have personally benefited from XWELL while overseeing an astounding decline in XWELL shareholder value and substantial net losses. CPC also shares in the below letter its vision for restoring and maximizing shareholder value.
  • 07/24/2024

XWELL Announces Director Candidate Nomination Notice Submitted by CPC is Invalid

  • NEW YORK--(BUSINESS WIRE)--XWELL, Inc. (Nasdaq: XWEL) (“XWELL” or the “Company”), an authority in wellness solutions for people on the go, today announced that the notice materials submitted by CPC Pain & Wellness SPV, LLC (“CPC”), which purported to provide notice of CPC's intent to nominate four candidates for election to the Company's five-member Board of Directors (the “Board”) at the 2024 Annual Meeting of Stockholders, is invalid. CPC, a special purpose vehicle that was recently forme.
  • 07/22/2024

XWELL Opens New XpresSpa Location at Philadelphia International Airport

  • New location expands domestic footprint in busy Northeast corridor with labor lite tech forward service offerings New location expands domestic footprint in busy Northeast corridor with labor lite tech forward service offerings
  • 06/17/2024

XWELL Continues to Innovate in Airport Wellness Space with New Massage Solutions: Introducing Ceragem V6 in select XpresSpa® Locations in US

  • Expanded service offering underscores XWELL's ongoing focus on delivering cost-effective wellness services that drive top-line growth Expanded service offering underscores XWELL's ongoing focus on delivering cost-effective wellness services that drive top-line growth
  • 05/23/2024

XWELL, Inc. Reports First Quarter 2024 Results

  • NEW YORK, May 15, 2024 (GLOBE NEWSWIRE) --  XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, today reported results for the first quarter ended March 31, 2024.
  • 05/15/2024

XpresSpa Introduces IV Hydration Drip Therapy at Miami International Airport

  • Pilot program designed to expand service offerings and drive revenue growth Pilot program designed to expand service offerings and drive revenue growth
  • 05/02/2024

XWELL, Inc. (XWEL) Q4 2023 Earnings Call Transcript

  • XWELL, Inc. (XWEL) Q4 2023 Earnings Call Transcript
  • 04/16/2024

XWELL, Inc. Reports Fiscal Year 2023 Results

  • NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, today reported results for the year ended December 31, 2023.
  • 04/16/2024

XWELL, Inc. to Report Fiscal Year 2023 Financial Results on Tuesday, April 16, 2024

  • NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, today announced that it will report results for the year ended December 31, 2023, on Tuesday, April 16, 2024, after the market close. The announcement will be followed by a webcast and conference call at 5:00 p.m.
  • 04/16/2024

XWELL, Inc. Plans to File Form 12b-25 to Extend Filing Date of its Form 10-K

  • NEW YORK, April 01, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, today announced plans to file a Form 12b-25 with the U.S. Securities and Exchange Commission regarding its Annual Report on Form 10-K for the year ended December 31, 2023. Additional time is needed for the Company to compile and analyze supporting documentation in order to finalize the Form 10-K and in order to permit the Company's independent registered public accounting firm to complete its audit of the consolidated financial statements included in the Form 10-K. The Company currently anticipates filing the Form 10-K as soon as practicable.
  • 04/01/2024

CDC Traveler-based Genomic Surveillance Program to Expand to Two New US International Airports in Miami and Chicago

  • The TGS program, a leading example of biosecurity infrastructure, operates at a total of nine US locations and leverages voluntary nasal swabs as well as wastewater sampling from international travelers to detect more than 30 pathogens. BOSTON, March 12, 2024 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, the Centers for Disease Control and Prevention (CDC), and XpresCheck, by XWELL, Inc. (Nasdaq: XWEL), a leader in the delivery of onsite pathogen screening, today announced they are expanding the CDC's Traveler-based Genomic Surveillance program (TGS) to new collection locations at US international airports in Miami (MIA) and Chicago (ORD).
  • 03/12/2024

XWELL Appoints Veteran Consumer & Wellness Entrepreneur Gaëlle Wizenberg to its Board of Directors

  • NEW YORK, Dec. 15, 2023 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, today announced the appointment of Gaëlle Wizenberg to the Company's Board of Directors, effective January 1, 2024.   The Company also announced that Donald Stout, who joined XWELL's Board of Directors in 2012, will be retiring from his position.
  • 12/15/2023

XWELL Opens New XpresSpa Location in Abu Dhabi International Airport

  • Eleventh international wellness center is the latest move by XWELL to expand its global footprint Eleventh international wellness center is the latest move by XWELL to expand its global footprint
  • 11/15/2023

XWELL, Inc. Reports Third Quarter 2023 Results

  • Airport Spas Deliver Strong 39% Year-Over-Year Q3 Revenue Growth Naples Wax Center Acquisition Accelerates Future Off-Airport Growth Opportunities Further Airport Spa Expansion Internationally
  • 11/14/2023

Ginkgo Bioworks and XWELL Implement Expanded CDC Traveler-based Genomic Surveillance Program to Test for More than 30 Known Pathogens

  • The program can be an effective early warning system for public health and national security officials, leveraging voluntary nasal and wastewater sampling from international travelers at major U.S. airports BOSTON , Nov. 6, 2023 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, and XWELL, Inc. (Nasdaq: XWEL) today announced they are expanding their work with the U.S. Centers for Disease Control and Prevention's (CDC's) Traveler-based Genomic Surveillance program (TGS) to test for more than 30 additional priority pathogens, in addition to SARS-CoV-2. TGS is a flexible, multimodal platform that consists of three complementary approaches of sample collection from arriving international travelers at U.S. airports, including voluntary nasal swabbing, aircraft wastewater, and airport wastewater sampling to enhance early detection of new SARS-CoV-2 variants and other pathogens, and fills gaps in global surveillance.
  • 11/06/2023

XWELL's CEO Scott Milford Discusses Strategic Growth Plans During Recent Investor Fireside Chat

  • Highlights the Recent Acquisition of Naples Wax Center as Launch Pad for XWELL's Out of Airport Strategy Highlights the Recent Acquisition of Naples Wax Center as Launch Pad for XWELL's Out of Airport Strategy
  • 10/09/2023

XWELL Celebrates Breast Cancer Awareness Month with Philanthropic Nail Care Program

  • Proceeds from select XpresSpa nail care services to be donated to Susan G. Komen Proceeds from select XpresSpa nail care services to be donated to Susan G. Komen
  • 10/02/2023

XWELL's CEO Scheduled to Present at Upcoming Investor Fireside Chat on October 4, 2023

  • Scott Milford to Present at Water Tower Research Fireside Chat Series on Wednesday, October 4, 2023, at 2:30 p.m. E.T. Scott Milford to Present at Water Tower Research Fireside Chat Series on Wednesday, October 4, 2023, at 2:30 p.m. E.T.
  • 09/28/2023

XWELL, Inc. Announces 1-for-20 Reverse Stock Split

  • NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL), announced today that it will effect a 1-for-20 reverse stock split of its common stock effective at 5:00 pm Eastern Time on Wednesday, September 27, 2023. Shares of XWELL's common stock are expected to begin trading on a split-adjusted basis when markets open on Thursday, September 28, 2023.
  • 09/27/2023

XWELL Introduces New Stretch Service at XpresSpa

  • NEW YORK, Sept. 19, 2023 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, continues to evolve its service offerings with the introduction of a proprietary stretching service for XpresSpa locations nationally.
  • 09/19/2023

XWELL Grows Footprint Outside the Airport with Acquisition of Naples Wax Center

  • Transaction represents the first step in building XWELL's retail portfolio outside the airport and positions the Company for revenue growth and profitability Transaction represents the first step in building XWELL's retail portfolio outside the airport and positions the Company for revenue growth and profitability
  • 09/12/2023

XWELL, Inc. (XWEL) Q2 2023 Earnings Call Transcript

  • XWELL, Inc. (NASDAQ:XWEL ) Q2 2023 Results Conference Call August 14, 2023 5:00 PM ET Company Participants Suzanne Scrabis - CFO Scott Milford - CEO Operator Greetings. Welcome to XWELL's Second Quarter 2023 Earnings Conference Call.
  • 08/17/2023

XWELL Extends Collaboration with Centers for Disease Control and Prevention's Traveler-Based Genomic Surveillance Program

  • Since August 2021, the program has served as a critical monitoring system for biological threats, leveraging voluntary sampling from international travelers at major U.S. airports Since August 2021, the program has served as a critical monitoring system for biological threats, leveraging voluntary sampling from international travelers at major U.S. airports
  • 08/17/2023

XWELL, Inc. to Announce Second Quarter 2023 Financial Results on Monday, August 14

  • NEW YORK, Aug. 07, 2023 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in health and wellness solutions for people on the go, today announced that it will release second quarter 2023 financial results on Monday, August 14, 2023, after the market close. The announcement will be followed by a webcast and conference call at 5:00 p.m.
  • 08/07/2023

XWELL, Inc. to Announce First Quarter 2023 Financial Results on Monday, May 15

  • NEW YORK, May 11, 2023 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in health and wellness solutions for people on the go, today announced that it will release first quarter 2023 financial results on Monday, May 15, 2023, after the market close. The announcement will be followed by a webcast and conference call at 5:00 p.m.
  • 05/11/2023

XWELL, Inc. to Announce 2022 Financial Results on Monday April 17

  • NEW YORK, April 14, 2023 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in health and wellness solutions for people on the go, today announced that it will release fiscal year 2022 financial results on Monday, April 17, 2023, after the market close. The announcement will be followed by a webcast and conference call at 5:00 p.m.
  • 04/14/2023

7 Penny Stocks That Actually Have Buy Ratings

  • This article focuses on penny stocks with “buy” ratings from analysts. Analysts have access to information about  companies that retail investors cannot obtain.
  • 12/01/2022

XWELL, Inc. (XWEL) Q3 2022 Earnings Call Transcript

  • XWELL, Inc. (NASDAQ:XWEL ) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Omar Haynes - Interim CFO Scott Milford - CEO Operator Greetings, and welcome to XWELL's Third Quarter 2022 Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded on Thursday, November 10, 2020.
  • 11/13/2022

XWELL, Inc. to Announce Third Quarter 2022 Financial Results on Thursday, November 10

  • Webcast and Conference Call Scheduled for 4:30 PM ET Webcast and Conference Call Scheduled for 4:30 PM ET
  • 11/03/2022
Unlock
XWEL Ratings Summary
XWEL Quant Ranking